The aptamers market is experiencing a phenomenal upswing with an impressive Compound Annual Growth Rate (CAGR) of 8.5%. By the year 2023, the market value is projected to reach an astounding $1.2 billion. This exponential growth is driven by the increasing adoption of aptamers in various fields, including therapeutics, diagnostics, and research, owing to their unique properties and potential applications."
The report "Aptamers Market, By Type (Nucleic Acid and Peptides (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), By Application (Diagnostics, Therapeutics, and Research and Development), and Region - Global Forecast to 2030"
Sample link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3879
Key Highlights:
• In September 2018, Base Pair Biotechnologies was awarded for discovering aptamers to canine oncology biomarkers.
• In April 2019, Agilent and Somalogic sign agreement for supply of customized microarrays
Analyst view:
The aptamers market is witnessing a promising trajectory with an extraordinary CAGR of 16.90% and is expected to achieve an impressive value US$ 985.44 million by 2030. Analysts attribute this remarkable growth to the rising adoption of aptamers in diverse sectors such as therapeutics, diagnostics, and research. Aptamers' distinct properties, including high specificity and versatility, have made them a preferred choice in developing novel solutions for various medical and scientific challenges. As research and development in the aptamer field continue to expand, analysts remain optimistic about the market's potential for future advancements and commercial success.
Competitive players:
The prominent player operating in the global aptamers market includes Somalogic, Inc., Noxxan Pharma AG, Aptamer Science Inc., Aptagen, Inc, AM Biotechnologies LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., TriLink BioTechnologies, Inc.
To know more
Contact Us:
Sales
Prophecy Market Insights
U.S. 1 860 531 2574
RoW: 917775049802
Email- [email protected]
Website- www.prophecymarketinsights.com